CompaniesMomenta Pharmaceuticals

Momenta Pharmaceuticals

defunct

About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (15)

Total Trials

15

As Lead Sponsor

10

As Collaborator

5

Total Enrollment

254,730

By Phase

PHASE3: 4PHASE2: 3PHASE1/PHASE2: 2PHASE1: 3

By Status

COMPLETED: 12TERMINATED: 3

Clinical Trials Pipeline15 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

Today

Hover over trial bars to see details

Recent Trials

NCT04674800Collaborator

Extension Study of MYL-1701P-3001 for Safety and Efficacy

PHASE3Completed

52 participants

Started: Nov 23, 2020 · Completed: Apr 20, 2022

NCT03896295Lead Sponsor

An Extension Study of MOM-M281-004 to Evaluate the Safety, Tolerability, and Efficacy of M281 Administered to Patients With Generalized Myasthenia Gravis

PHASE2Terminated

37 participants

Started: Aug 6, 2019 · Completed: Dec 9, 2020

NCT03772587Lead Sponsor

A Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults With Generalized Myasthenia Gravis

PHASE2Completed

68 participants

Started: Apr 10, 2019 · Completed: Jun 25, 2020

NCT03866577Lead Sponsor

Safety and Tolerability of M254 in Healthy Volunteers and Immune Thrombocytopenic Purpura (ITP) Patients

PHASE1/PHASE2Terminated

50 participants

Started: Dec 21, 2018 · Completed: Jun 9, 2021

NCT03610646Collaborator

Comparative Study to Evaluate the Efficacy and Safety of MYL-1701P and Eylea® in Subjects With Diabetic Macular Edema (DME)

PHASE3Completed

355 participants

Started: Aug 23, 2018 · Completed: Sep 10, 2021

View all 15 trials →

Funding History (20)

8-K

Oct 1, 2020

8-K

Aug 19, 2020

8-K

Aug 10, 2020

8-K

Jun 24, 2020

8-K

Jun 15, 2020

8-K

May 7, 2020

DEF 14A

Apr 24, 2020

8-K

Apr 10, 2020

8-K

Apr 2, 2020

8-K

Feb 26, 2020

Related Companies

J&j

acquired